Newsletter | November 23, 2022

11.23.22 -- Merck, Medimmune, And Keytruda: An Ultimate Outsourcing Story
 
From The Editor
Merck, Medimmune, And Keytruda: An Ultimate Outsourcing Story
 
By Louis Garguilo, chief editor, Outsourced Pharma

What's revealed in this editorial illuminates the highest possibilities of the strategic and tactical application of manufacturing outsourcing. “I put a pretty famous deal together with Merck, as an example,” Darren Dasburg says suddenly during a discussion on developing business requirements ... Here’s the remarkable story behind that deal.
Industry Insights
Starting Your Sterile Injectables Program Off On The Right Foot
Article | By Jennifer Quint and Daniel Lenz, Pfizer CentreOne

How can drug sponsors and developers leverage these increasingly strategic commercial fill/finish partnerships? Explore tips on how to put programs on a firmer footing.
The 3 Cs You Should Expect From Your Pharma Service Provider
White Paper | By Yves Massicotte, Ropack Pharma Solutions

Learn what indicates whether a service provider has the capabilities desired by a drug sponsor to fulfill a company’s long-term goals and is committed to their success.
Overcoming Limitations To Achieve Uniform Dosing
Case Study | By Tracy Milburn, Cambrex

An immediate need for lower dose capsules in the clinic posed several challenges in blend formulation with very tight timelines for delivery.
Solutions
Clinical Trial Supply Chain Services
Sharp
AseptiQuik G DC Series Connectors
CPC
Outsourced Pharma Live
 

Available On Demand! Throughout the year, chief editor Louis Garguilo brings together industry experts to discuss some of the biggest challenges being faced by both sponsors and CDMOs. Our archived videos can be accessed at any time by registered site users.